Table 1 Antimicrobial resistance rates among P. aeruginosa (% resistant)
Antimicrobial | Hospitalized patients n = 9 | Environment n = 33 | Total N = 42 |
|---|---|---|---|
Beta-lactam agents | |||
 Aztreonam | 4 (44%) | 16 (48%) | 20 (48%) |
 Cefepime | 3 (33%) | 0 | 3 (7%) |
 Ceftazidime | 5 (56%) | 14 (42%) | 19 (45%) |
 Imipenem | 3 (33%) | 7 (21%) | 10 (24%) |
 Meropenem | 0 | 0 | 0 |
 Piperacillin–tazobactam | 5 (56%) | 21 (64%) | 26 (62%) |
Aminoglycosides | |||
 Amikacin | 2 (22%) | 4 (12%) | 6 (14%) |
 Gentamicin | 5 (56%) | 13 (39%) | 18 (43%) |
Quinolones | |||
 Ciprofloxacin | 7 (78%) | 13 (39%) | 20 (48%) |